FDA Warning Letter — BP

Case 521129 — FEI 3013372175

The FDA took a Warning Letter action against BP on Mar 30, 2017 (Ozone Park, NY). The action was issued by CTP and concerns tobacco products.

Action Details

Facility
BP
Date
Mar 30, 2017
Fiscal Year
2017
Product Type
Tobacco
Center
CTP
Location
Ozone Park, NY (United States)

Sources: openFDA, FDA Data Dashboard, FDA.gov. Report a data issue: hello@regdatalab.com.